Systems and methods to facilitate delivery of a therapeutic agent into the skin of a subject

US11413092B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11413092-B2
Application numberUS-201716069951-A
CountryUS
Kind codeB2
Filing dateJan 9, 2017
Priority dateJan 13, 2016
Publication dateAug 16, 2022
Grant dateAug 16, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure is directed to systems and methods that facilitate delivery of a therapeutic agent into the skin of a subject. A first mechanism can create a first angled channel through a first location on a surface of a subject's skin at a first angle relative to the surface of the subject's skin. A second mechanism, associated with the first mechanism, can create a second angled channel through a second location on the surface of the subject's skin at a second angle relative to the surface of the subject's skin. The first angled channel and the second angled channel intersect to form a connected channel under the surface of the subject's skin.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of dermal drug delivery into skin of a subject beneath the subject's stratum corneum, the method comprising the steps of: emitting, by a radiation source, a laser beam; splitting, by a scanner at an output of the radiation source, the laser beam into a first portion and a second portion; directing, by a first mirror, the first portion to a first location on the skin of the subject, the first mirror being configured to be positioned at a first angle relative to the surface of the subject's skin; forming, by the first portion, a first channel at the first angle from the first location to a point in the skin of the subject beneath the subject's stratum corneum; directing, by a second mirror, the second portion to a second location on the skin of the subject, different from the first location, the second mirror being configured to be positioned at a second angle different from the first angle and not normal to the surface of the subject's skin; forming, by the second portion, a second channel at the second angle from the second location to the point to form a connected channel under the skin of the subject beneath the subject's stratum corneum by an intersection of the first channel and the second channel at the point; applying the dermal drug to the subject's skin topically; and delivering the dermal drug into the subject's stratum corneum through the connected channel through the first angled channel and/or the second angled channel, wherein the connected channel permits fluid flow of the dermal drug within the first angled channel, the second angled channel, and the connected channel with reduced back pressure. 2. The method of claim 1 , further comprising pulling the subject's skin into a vacuum chamber and forming the first angled channel and the second angled channel in the pulled skin. 3. The method of claim 1 , wherein the fluid flow of the dermal drug is permitted with reduced back pressure because of the presence of fewer air bubbles in the connected channel. 4. The method of claim 1 , wherein applying the dermal drug blocks at least one side of the connected channel. 5. The method of claim 4 , further comprising removing the dermal drug blocking the at least one side of the connected channel by swiping the dermal drug away from the connected channel. 6. The method of claim 5 , wherein the swiping is performed with at least one finger of a person.

Assignees

Inventors

Classifications

  • with pivotable mirrors · CPC title

  • Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04) · CPC title

  • Skin · CPC title

  • Intradermal administration, e.g. through microneedle arrays or needleless injectors · CPC title

  • Auxiliary appliance · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11413092B2 cover?
The present disclosure is directed to systems and methods that facilitate delivery of a therapeutic agent into the skin of a subject. A first mechanism can create a first angled channel through a first location on a surface of a subject's skin at a first angle relative to the surface of the subject's skin. A second mechanism, associated with the first mechanism, can create a second angled chann…
Who is the assignee on this patent?
Massachusetts Gen Hospital
What technology area does this patent fall under?
Primary CPC classification A61B18/203. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).